Who buys plastic surgery practices has changed a lot in a decade. It used to be a short list: a younger associate, a surgeon moving into town, or nobody at all, in which case the practice simply wound down. Today a surgeon-owner with a healthy practice may hear from private equity-backed platforms, management services organizations, dermatology groups expanding into surgery and other surgeons, sometimes in the same month.
That’s good news, if you know how each buyer thinks. This guide explains the five main types of buyer, what each typically pays, how private equity and MSO deals are structured, the scrutiny these buyers face, and how to choose the right one for your goals.
Key takeaways
- Five buyer types are active: private equity platforms, platform add-on buyers, other surgeons, aesthetics and dermatology groups, and hospital or multispecialty systems.
- Physician Growth Partners counts ten or more PE-backed plastic surgery platforms, including Athenix, Ascend Plastic Surgery Partners and Olympus Cosmetic Group (PGP).
- Private equity usually pays the most for larger practices but asks for rollover equity and a multi-year employment agreement.
- The right buyer depends on your size, your goals and how much control you want to keep.
Who buys plastic surgery practices?
Five types of buyer acquire plastic surgery practices: private equity firms forming new platforms, PE-backed platforms buying add-ons, other surgeons or small groups, aesthetics and dermatology groups adding surgical capability, and hospitals or multispecialty groups, mainly for reconstructive practices. For most independent practices, the realistic buyers are add-on platforms and other surgeons.
Each type values different things. A platform wants surgeons who will grow with it. An add-on buyer wants a practice that fits its geography and systems. A surgeon buyer wants patients and a location. Knowing who you’re talking to helps you understand their offer, and what they’ll expect from you after closing.
Why are so many buyers interested in plastic surgery?
Because demand is growing, patients mostly pay cash, and the market is still fragmented. ASPS reported cosmetic surgical procedures up 7% in 2025, and most plastic surgery practices remain independently owned. That combination is exactly what a buy-and-build investor looks for: steady demand and many small practices to combine.
The patient trend is strong. The American Society of Plastic Surgeons said lift procedures led 2025 growth, and patients 66 and older rose 24%. Physician Growth Partners’2024 white paper described the market as “heavily fragmented, with the majority of plastic surgery practices still independently owned,” with most services paid in cash.
Deal activity reflects that interest. FOCUS Investment Banking reported a 440% increase in plastic surgery deal volume over the two years to 2024.
The 5 types of plastic surgery practice buyers
1. Private equity platforms
A platform is the first practice a private equity firm buys in a specialty or region, usually a larger group with strong leadership, which then becomes the base for further acquisitions. Platforms pay the highest multiples because they’re buying a foundation.
Physician Growth Partners lists active PE-backed plastic surgery platforms and their sponsors, including:
| Platform | Private equity sponsor |
| Athenix | Latticework Capital Management |
| Inspire Aesthetics | Hidden Harbor Capital Partners |
| Ascend Plastic Surgery Partners | Sheridan Capital Partners |
| Olympus Cosmetic Group | VSS Capital Partners |
| United Aesthetics Alliance | Varsity Healthcare Partners |
| Advanced Reconstructive Surgery Alliance | Webster Equity Partners |
Sources: Physician Growth Partners and its 2024 white paper. Ownership changes over time, so confirm current sponsors before you talk to any of them.
2. Platform add-on buyers
Once a platform exists, it grows by adding practices. Most independent plastic surgery practices meet private equity this way: as an add-on. FOCUS reported add-on acquisitions at 5x to 9x EBITDA in 2026, generally below platform pricing, but often with faster, simpler integration.
3. Other surgeons and small groups
A surgeon buying your practice, or an associate buying in over time, remains common for smaller practices. TUSK Practice Sales says doctor-to-doctor sales are common for practices under $2 million in revenue (PR Newswire). Prices are usually lower and may include seller financing, but you keep things simple and often protect your practice culture.
4. Aesthetics and dermatology groups
Some PE-backed dermatology and aesthetics groups add plastic surgery to offer a full range of treatments. FOCUS points to DermCare Management, an aesthetics-linked dermatology platform, as having completed 22 add-on acquisitions since 2021. These buyers value your surgical capability and patient base, and may already have injectables and skin care infrastructure.
5. Hospitals and multispecialty groups
For practices with substantial reconstructive or insurance-based work, hospitals, academic centers and multispecialty groups can be buyers or employers. They usually offer stability and employment rather than a large purchase price, and less upside.
What do plastic surgery practice buyers look for?
Whoever buys plastic surgery practices in your area, they look for the same core things: more than one productive surgeon, growing consultations and case volume, a mix of surgical and non-surgical revenue, clean financials, a recognizable practice brand and a compliance record without surprises. The more of these you have, the more buyers compete.
Different buyers weigh them differently:
- Platforms care most about leadership, growth potential and whether you can help recruit other surgeons.
- Add-on buyers focus on geographic fit, how easily your systems can be integrated and whether your patient base overlaps with theirs.
- Surgeon buyers focus on patient volume, your location and whether your team will stay.
- Aesthetics groups look at your non-surgical revenue and how surgery fits their existing services.
FOCUS lists revenue diversification, multi-provider depth, ancillary revenue, facility ownership, brand equity and geographic density among the characteristics that command premium valuations in 2026.
How does a plastic surgery MSO deal work?
In most states, a private equity firm can’t directly own a medical practice. Instead, it buys a management services organization (MSO), which buys the practice’s non-clinical assets and provides management, marketing and administrative services under a long-term agreement. A physician-owned professional entity keeps control of clinical care.
This arrangement exists because of the corporate practice of medicine doctrine, which in many states limits who can own a practice or direct clinical decisions. DLA Piper describes the model this way: a licensed professional owns the professional entity and controls clinical services, while the MSO provides administrative support through a management services agreement.
For you as a seller, that usually means:
- You sell non-clinical assets and goodwill to the MSO for cash and equity
- A professional entity, often owned by a physician, continues to employ clinicians
- You sign an employment agreement with the professional entity
- The MSO earns a management fee that captures most of the practice’s profit
- You may receive rollover equity in the MSO or its parent
Selling a plastic surgery practice to private equity: what to expect
Expect a higher headline price than most other buyers offer, paid partly in cash and partly in rollover equity, sometimes with an earnout, plus a multi-year employment agreement and a non-compete. The buyer will want you to keep operating and help recruit other surgeons. In return you get capital, systems and a second payday if the platform sells well.
TUSK notes that most transactions combine upfront cash, rollover equity and sometimes earnouts, with employment agreements typically running three to five years. Private equity firms also work on a clock. FOCUS describes a five-to-seven-year hold period in physician practice underwriting, which shapes how the buyer plans growth and when it expects to sell.
The things to understand before you sign:
- How much cash you get at closing, after working capital and escrow adjustments
- How much rollover equity, how much debt sits ahead of it and when the fund expects to exit
- Your post-sale compensation formula and how it’s calculated
- Your role, schedule, call and clinical independence
- The non-compete and how it applies if you leave early
- What happens to your staff, brand and patient experience
For how to evaluate the equity portion, see our guide to plastic surgery rollover equity.
What scrutiny do private equity buyers face?
Rising scrutiny from state attorneys general, legislators and researchers, focused on corporate control of clinical decisions, pricing and transparency. California’s attorney general reached corporate practice settlements in 2026, and Vermont passed a law barring private equity from interfering with clinical judgment. Sellers should expect buyers to structure deals carefully.
The broader shift is real. The Milbank Memorial Fund reports that nearly 80% of physicians are now employed by or affiliated with hospitals, health systems or corporate entities, with non-hospital corporate owners at 30.1% compared with 28.4% for hospitals. DLA Piper notes a $4.5 million California settlement with Carbon Health in June 2026 over MSO control of functions like advertising and payer negotiations, and Vermont’s Act 133, effective July 1, 2026.
For a surgeon, the practical point is simple: make sure your post-sale agreements protect your clinical independence, and ask each buyer how its structure complies with your state’s rules.
Who buys plastic surgery practices in smaller markets?
Fewer private equity platforms, more surgeon buyers and regional groups. Platforms tend to build first in large, affluent metro areas with dense patient demand. A practice in a smaller market may still attract an add-on buyer expanding its footprint, but internal succession and surgeon-to-surgeon sales play a bigger role there.
That doesn’t mean smaller-market practices can’t sell well. A strong local brand, an owned surgical facility and an associate surgeon who plans to stay all make a practice attractive to regional buyers. Starting early matters more, because the buyer pool is smaller and the right buyer may take longer to find. Our guide to putting a plastic surgery practice for sale covers timing and how consolidation affects each market.
When should you start talking to buyers?
Earlier than you think, but not before you’re ready. Many surgeons first hear from buyers through unsolicited calls. Treat those as information, not offers. Before you share anything detailed, get your financials recast and understand your options, so any conversation starts from your numbers rather than the buyer’s.
What about unsolicited offers?
They’re common, and they’re worth answering politely, but rarely worth accepting as is. An unsolicited offer tells you a buyer sees value in your practice. It doesn’t tell you what other buyers would pay, or whether the structure is fair. Understanding who buys plastic surgery practices like yours, and what they’ve paid recently, is the only way to judge it.
If a buyer calls:
- Thank them and ask who they are, who backs them and what they’re building in your region.
- Share nothing detailed until they sign a confidentiality agreement.
- Get an independent view of your value before discussing numbers.
- Consider testing the market quietly with a few other qualified buyers.
Private equity or surgeon buyer: which is the best fit?
Choose private equity if you want the strongest price, capital to grow and help with operations, and you’re comfortable with rollover equity and a few years under new ownership. Choose a surgeon buyer or internal succession if independence, culture and simplicity matter more. Running a process that includes several buyer types lets you compare real offers.
| Priority | Stronger fit |
| Highest total value | PE platform or competitive add-on |
| Capital to add surgeons or locations | PE platform |
| Keeping control and culture | Surgeon buyer or internal succession |
| Simple, fast deal | Surgeon buyer or add-on |
| Second liquidity event | PE deal with rollover equity |
| Reconstructive or insurance focus | Hospital or multispecialty group |
How do you vet plastic surgery practice buyers?
Ask each buyer about its ownership and fund timeline, debt levels, how its existing surgeons are paid, how many surgeons have left after joining, and how it handles marketing and clinical decisions. Then speak with surgeons who sold to it. A good buyer answers these questions openly and lets you talk to its partners.
Useful questions for surgeons who’ve already sold to the buyer:
- Did the post-sale compensation match what you were promised?
- How much say do you still have over scheduling, staffing and marketing?
- How has the patient experience changed?
- What happened to your staff?
- Would you do it again?
How do you get the right buyers to the table?
Through a confidential, competitive process managed by an advisor who knows plastic surgery buyers personally. A single inbound offer shows you one buyer’s view. Several competing offers reveal your practice’s real value and give you bargaining power on terms like rollover, compensation and non-competes.
Before you start, get your numbers in order. Our guide to plastic surgery practice valuation explains how buyers price your practice, and our guide on how to sell a plastic surgery practice walks through the full process step by step.
Frequently asked questions
Who buys plastic surgery practices?
Private equity-backed platforms and MSOs, platform add-on buyers, other surgeons and small groups, aesthetics and dermatology groups adding surgery, and hospitals or multispecialty groups for reconstructive practices. Larger practices draw private equity interest; smaller practices more often sell to other surgeons, sometimes through an associate buy-in over several years.
Is private equity buying plastic surgery practices?
Yes. Physician Growth Partners lists ten or more PE-backed plastic surgery platforms, including Athenix, Inspire Aesthetics, Ascend Plastic Surgery Partners and Olympus Cosmetic Group. FOCUS Investment Banking reported a 440% increase in plastic surgery deal volume over the two years to 2024, and buyers expect continued activity.
What is a plastic surgery MSO?
A management services organization that provides non-clinical services, like marketing, billing, staffing and administration, to plastic surgery practices. In a private equity deal, the MSO usually buys the practice’s non-clinical assets, while a physician-owned entity keeps clinical control, to comply with state corporate practice of medicine rules.
How much do private equity buyers pay for plastic surgery practices?
FOCUS Investment Banking reported 2026 platform deals at 5x to 12x or more EBITDA depending on size, with add-ons at 5x to 9x. Offers usually combine cash at closing with rollover equity, and sometimes an earnout, so compare the guaranteed cash as well as the headline number.
Can I sell my practice and keep operating?
Yes, and most buyers expect it. Private equity and MSO buyers generally want the selling surgeon to keep operating under an employment agreement, often three to five years according to TUSK Practice Sales. Surgeon buyers may offer shorter transitions. Your role, pay and schedule are negotiated before closing.
What happens to my staff when I sell to private equity?
Most buyers keep clinical and front-office staff, because they hold patient relationships. Administrative roles like billing and marketing may be centralized over time. Ask each buyer about wages, benefits and roles, speak with surgeons who’ve sold to them, and put important commitments in the purchase agreement.
Who buys plastic surgery practices: the bottom line
Who buys plastic surgery practices today is a longer list than ever, from private equity platforms to surgeon buyers. Match the buyer to your goals, understand how each structures a deal, vet their track record with surgeons who’ve sold before, and let competition set your price.
| Heard from a buyer already? Get the Plastic Surgery Exit Report newsletter for quarterly buyer updates, or book a confidential conversation with the plastic surgery team at Olympic M&A before you respond. Disclosure: Plastic Surgery Exit Report is published in partnership with Olympic M&A, a healthcare M&A advisory firm. |
